Placebo-Controlled Trial of Cytisine for Smoking Cessation
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Cytisine, a partial agonist that binds with high affinity to the α(4)β(2) nicotinic acetylcholine receptor, is a low-cost treatment that may be effective in aiding smoking cessation. This study assessed the efficacy and safety of cytisine as compared with placebo. METHODS: We conducted a single-center, randomized, double-blind, placebo-controlled trial. Participants were randomly assigned to receive cytisine or matching placebo for 25 days; participants in both groups received a minimal amount of counseling during the study. The primary outcome measure was sustained, biochemically verified smoking abstinence for 12 months after the end of treatment. Of 1542 adult smokers screened, 740 were enrolled and 370 were randomly assigned to each study group. RESULTS: The rate of sustained 12-month abstinence was 8.4% (31 participants) in the cytisine group as compared with 2.4% (9 participants) in the placebo group (difference, 6.0 percentage points; 95% confidence interval [CI], 2.7 to 9.2; P=0.001). The 7-day point prevalence for abstinence at the 12-month follow-up was 13.2% in the cytisine group versus 7.3% in the placebo group (P=0.01). Gastrointestinal adverse events were reported more frequently in the cytisine group (difference, 5.7 percentage points; 95% CI, 1.2 to 10.2). CONCLUSIONS: In this single-center study, cytisine was more effective than placebo for smoking cessation. The lower price of cytisine as compared with that of other pharmacotherapies for smoking cessation may make it an affordable treatment to advance smoking cessation globally.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire
HEATHERTON, T. F., KOZLOWSKI, L. T., FRECKER, R. C., & FAGERSTROM, K. (1991) · British Journal of Addiction · doi:10.1111/j.1360-0443.1991.tb01879.x · Cited by 10,738
Mortality in relation to smoking: 40 years' observations on male British doctors
Doll, R., Peto, R., Wheatley, K., Gray, R., & Sutherland, I. (1994) · BMJ · doi:10.1136/bmj.309.6959.901 · Cited by 5,932
Mortality in relation to smoking: 50 years' observations on male British doctors
Doll, R., Peto, R., Boreham, J., & Sutherland, I. (2004) · BMJ · doi:10.1136/bmj.38142.554479.ae · Cited by 2,920 · cited 1×
“Purportedly, every year that a smoker delays quitting beyond the mid-30s subtracts 3 months of life expectancy.(2) However, of the more than 1 billion smokers around the globe, two thirds reside in countries where the average household income is less than $200 per week and where therapy for this kind is not paid for b…”
BackgroundMoher, D. (2001) · JAMA · doi:10.1001/jama.285.15.1987 · Cited by 2,545
Nicotine replacement therapy for smoking cessation
Stead, L. F., Perera, R., Bullen, C., Mant, D., Hartmann-Boyce, J., Cahill, K., & Lancaster, T. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000146.pub4 · Cited by 2,464
Assessment of Depression: The Depression Inventory
Beck, A. T., & Beamesderfer, A. (2015) · Modern Trends in Pharmacopsychiatry · doi:10.1159/000395074 · Cited by 1,832
Mackay, J. M., & Eriksen, M. P. (2002) · Medical Entomology and Zoology · Cited by 1,431
Shape of the relapse curve and long-term abstinence among untreated smokers
Hughes, J. R., Keely, J., & Naud, S. (2004) · Addiction · doi:10.1111/j.1360-0443.2004.00540.x · Cited by 1,414 · cited 1×
“It is a highly addictive habit, with more than 95% of unaided attempts at cessation failing to last 6 months.(1) Purportedly, every year that a smoker delays quitting beyond the mid-30s subtracts 3 months of life expectancy.”
BackgroundAntidepressants for smoking cessation
Howes, S., Hartmann-Boyce, J., Livingstone-Banks, J., Hong, B., & Lindson, N. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000031.pub5 · Cited by 1,352
Outcome criteria in smoking cessation trials: proposal for a common standard
West, R., Hajek, P., Stead, L., & Stapleton, J. (2005) · Addiction · doi:10.1111/j.1360-0443.2004.00995.x · Cited by 1,285
Self-citation
Research works printed but not linked: 5
- Cahill K, 2010, Cochrane Database Syst Rev, 12, CD006103
- Stead LF, 2008, Cochrane Database Syst Rev, 1, CD000146
- Hughes JR, 2007, Cochrane Database Syst Rev, 1, CD000031
- Tutka P, 2006, Pharmacol Rep, 58, 777
- Stoyanov S, 1965, Chimpharm Sofia, 2, 13
Cited by
Items 201–234 of 234
Can the use of varenicline improve the efficacy of pharmacotherapy for nicotine addiction?
Mazur, R., Masternak, S., Pająk, M., Skoczeń, N., Soroka, E., & Olajossy, M. (2019) · Current Problems of Psychiatry · doi:10.2478/cpp-2019-0002
Sasiadek, J., Durham, N., & George, T. P. (2020) · Springer eBooks · doi:10.1007/978-3-030-36391-8_15
Raucherentwöhnung mit Fokus auf onkologische Patienten*
Bauer-Kemény, C., & Kreuter, M. (2022) · InFo Hämatologie + Onkologie · doi:10.1007/s15004-022-8951-4
Gültzow, T. (2022) · Research Publications (Maastricht University) · doi:10.26481/dis.20220308tg · Cited by 4
The Cellular Effects of Nicotine and Tobacco Particulate Matter on Monoamine Transporters
Danielson, K. (2013) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.17003674
Mackowick, K. M., & George, T. P. (2014) · Springer eBooks · doi:10.1007/978-88-470-5322-9_17
Oxidative Fragmentation of Cytisine as an Entry to the Bis(piperidine) Scaffold of Virgidivarine
Gallagher, T. C., & Niwetmarin, W. (2022) · Heterocycles · doi:10.3987/com-22-s(r)21
Николаевич, Б. С., Trufanova, G. Y., Медведева, И. В., Егорова, Ю. В., Berezina, E. I., & Platonov, D. Y. (2022) · Medicina · doi:10.29234/2308-9113-2022-10-3-13-28
Citisiniclina no Tratamento Farmacológico da Cessação Tabágica: Uma Revisão Baseada na Evidência
Vicente, A. F., & Lourenço, O. B. (2022) · Gazeta Médica · doi:10.29315/gm.v1i1.592
EPIDEMIOLOGIA PALENIA TYTONIU I METODY EFEKTYWNIE WSPIERAJĄCE WALKĘ Z UZALEŻNIENIEM OD NIKOTYNY
Wahl, W., Jędrzejczyk-Okońska, D., & Fronczak, A. (2019) · Prospects in Pharmaceutical Sciences · doi:10.56782/pps.28
Innovaciones en la cesación tabáquica: el papel de la citisiniclina
Álvarez-Mon, M. Á., & Herrera, V. (2024) · Psiquiatría Biológica · doi:10.1016/j.psiq.2024.100513
Innovative pharmakologische Ansätze zur Behandlung von Suchterkrankungen
Mick, I., Müller, C. A., & Majić, T. (2024) · Elsevier eBooks · doi:10.1016/b978-3-437-21074-7.00008-3
(2024) · Elsevier eBooks · doi:10.1016/b978-3-437-21074-7.00016-2
Ruiz-Salcedo, S., Ranchal‐Sánchez, A., Moruno, J. R., Montserrat-Villatoro, J., Jurado‐Castro, J. M., & Rodríguez, E. M. R. (2024) · Healthcare · doi:10.3390/healthcare12242516
Secondary Metabolites Production and Yield of Oilseed Plants
Ahmed, M., Thakur, P., Kamble, V. P., Wani, A. W., Kumar, S., Zarina, Z., & Zimare, S. B. (2025) · Wiley eBooks · doi:10.1002/9781394186426.ch10
Mir, H. R., Mullen, K., Heshmati, J., Baldwin, A., Quirouette, E., Serano, E., Coja, M., Pipe, A., & Reid, R. D. (2025) · CJC Open · doi:10.1016/j.cjco.2025.05.005
Tashkin, D. P., & Melamed, K. H. (2025) · Thorax · doi:10.1136/thorax-2025-224162
Castedo, C. R., Estany‐Gestal, A., Ruiz, C. A. J., de Granda‐Orive, J. I., Riesco, J. A., Fernández, M. I. C., Pinedo, Á. R., Signes‐Costa, J., Unzueta, M. I. G., Morales, A. S. V., et al. (2025) · JMIR Research Protocols · doi:10.2196/76815
Huang, W.-C., Marks, G. B., Pham, N. Y., Nguyen, T. A., Nguyen, T. A., Vu, V. G., Nguyen, V. N., Jan, S., Negin, J., Ngô, Q. C., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19596207
Pan, J., Wu, X., Meng, F., Xu, F., & Zhou, W. (2026) · BMC Public Health · doi:10.1186/s12889-025-26171-w
Quintana, A. G., Pérez, M. L., & Piro, V. (2026) · REC CardioClinics · doi:10.1016/j.rccl.2025.12.003
Riglietta, M., Daffini, L., Banalotti, P., Caminada, S., Cheli, F., Chiara, F., Carbone, G. S., Donadoni, P., Fumagalli, P., Marenzi, R., et al. (2026) · MISSION · doi:10.3280/mis72-2025oa21255
Mussio, I., Triunfo, P., & Gerstenblüth, M. (2026) · BMJ Open · doi:10.1136/bmjopen-2025-113050
The therapeutic potential of cytisine and its derivatives in disorders of the central nervous system
Cheng, M., Zhu, D., Chen, S., Jia, J., Xu, J., & Zeng, X. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.117853
Understanding Nicotine Addiction: Personalizing Therapy for Smoking Cessation
Stein, J., Minkin, R., Parikh, M. A., RAFIAA, M., Frishman, W. H., & Peterson, S. J. (2026) · Cardiology in Review · doi:10.1097/crd.0000000000001221
The role of cytisinicline in the treatment of nicotine dependence
Slíva, J. (2026) · Medicína pro praxi · doi:10.36290/med.2026.018
Brath, H., Huber, S., Parzer, V., Riesenhuber, M., Tatschl, C., Fasching, P., & Clodi, M. (2026) · Wiener klinische Wochenschrift · doi:10.1007/s00508-025-02680-x
Duru, S. A., Kerem, B., Demirkaya, A., & Aydın, G. (2026) · Tobacco Induced Diseases · doi:10.18332/tid/219641 · Cited by 1
Walicka, M., Russo, C., Ceriello, A., George, J., Campagna, D., Misra, A., Rosa, G. R. M. L., Sammut, R., & Polosa, R. (2026) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2026.113528
Mutlu, H. H., Erdem, F., & Mutlu, H. H. (2026) · Healthcare · doi:10.3390/healthcare14183090
Biochemical and Sensory Dimensions of Plant–Human Interactions
Yeşil, P. (2026) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub1564.c6401
Metadata
- Authors
- West, R., Zatonski, W., Cedzynska, M., Lewandowska, D., Pazik, J., Aveyard, P., & Stapleton, J.
- Affiliations
- Cancer Research UK (GB)
- The Maria Sklodowska-Curie National Research Institute of Oncology (PL)
- University of Birmingham (GB)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2011-09-29
- Volume
- 365
- Issue
- 13
- Pages
- 1193-1200
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2023431702
- Cited by
- 234
- References
- 25
- Citations by year
- 2026: 14 · 2025: 11 · 2024: 13 · 2023: 11 · 2022: 21 · 2021: 13 · 2020: 9 · 2019: 10 · 2018: 16 · 2017: 10 · 2016: 11 · 2015: 14 · 2014: 16 · 2013: 28 · 2012: 28
- FWCI
- 17.19
- Type
- journal article
- Language
- en
- Open access
- Licence
- other-oa
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion, other-oa)
- Research Portal (King's College London) (publishedVersion, other-oa)
- UCL Discovery (University College London) (submittedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Research Publications (Maastricht University) (submittedVersion)
- Funders
- Cancer Research UK
- National Institute for Health and Care Research
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Keywords
- cytisine, smoking cessation, nicotine dependence, nicotinic acetylcholine receptors, smoking abstinence, pharmacotherapy, gastrointestinal adverse effects, low-cost treatment
- MeSH terms
- Adult, Cystine, Double-Blind Method, Female, Gastrointestinal Diseases, Humans, Male, Middle Aged, Placebos, Smoking Cessation, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.